SP1049C treatment decreases tumor aggressiveness. by Daria Y. Alakhova (447558)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Kisspeptin-10 decreases blood flow in the peripheral vasculature. by Iain Sawyer (356468)

Binding mode of clavulanic acid with active site residues of SHV wt at different time intervals (a) binding of ca at 0 ns (b) binding of ca at 2 ns (c) binding of ca at 5 ns (d) bi... by Mohd Hassan Baig (441304)

BSO and AUR decreased cell viability and clonogenic survival. by Arya Sobhakumari (300950)

Diclofenac decreases glucose consumption and modulates lactate accumulation. by Eva Gottfried (431785)

MEK inhibition decreases mTOR activity in T cells. by Marie Le Borgne (337225)

Myocardial autophagy was decreased after nonlethal mechanism trauma. by Jie Wang (16762)

Pyrimidine nucleotides are decreased in hypoxia, while precursors accumulate. by Emily B. Cohen (9106088)

Coronavirus replication is decreased in AMPK-knockout (KO) cells. by Minsu Jang (2817730)

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

Pretreatment of Huh-7.5.1 cells with PF-429242 results in a robust decrease in intracellular DENV-2 RNA and post-treatment of DENV-2 infected Huh-7.5.1 cells with PF-429242 impairs the assembly and/or release of infectious virus particles. by Anastasia Hyrina (3860455)

Near anoxia decreases expression of stemness-related markers. by Rohini L. Kadle (4919335)

The geometric mean diameter and total quantity concentration of particulate matter corresponding to different lubricating oils. by Xin Kuang (17390340)

Subjects:

miR-145 decreases glioma cell migration. by Hae Kyung Lee (285269)

Decreased energy intake in Het GIP Tg mice. by Su-Jin Kim (90561)

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

“…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”

GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

“…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10³ cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue^® assay. …”

Decreased recruitment of pDCs and CD8⁺ T lymphocytes and higher recruitment of neutrophils to the lung of infected ChemR23-deficient mice. by Benjamin Bondue (153816)